Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
22.92B | 22.09B | 21.07B | 21.19B | 20.95B | 19.94B | Gross Profit |
5.60B | 5.35B | 4.47B | 4.57B | 4.34B | 4.34B | EBIT |
1.25B | 1.27B | 873.93M | 948.75M | 769.55M | 714.75M | EBITDA |
1.88B | 2.72B | 2.28B | 2.29B | 2.04B | 2.08B | Net Income Common Stockholders |
846.32M | 936.47M | 682.48M | 638.17M | 497.04M | 475.96M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.59B | 6.59B | 5.88B | 5.40B | 4.54B | 4.19B | Total Assets |
20.82B | 20.82B | 20.12B | 18.60B | 19.13B | 16.56B | Total Debt |
2.05B | 2.05B | 2.06B | 1.38B | 1.55B | 1.54B | Net Debt |
-4.54B | -4.54B | -3.82B | -4.02B | -2.99B | -2.65B | Total Liabilities |
6.97B | 6.97B | 6.68B | 5.69B | 6.62B | 4.57B | Stockholders Equity |
13.85B | 13.85B | 13.44B | 12.91B | 12.50B | 11.99B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.70B | 1.09B | 1.58B | 1.05B | 926.12M | Operating Cash Flow |
0.00 | 2.51B | 1.71B | 2.12B | 1.75B | 1.66B | Investing Cash Flow |
0.00 | -595.27M | -475.22M | -518.83M | -702.38M | -624.09M | Financing Cash Flow |
0.00 | -1.20B | -756.48M | -744.15M | -699.29M | -704.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥13.48B | 9.56 | 3.82% | 10.04% | 99.20% | ||
82 Outperform | ¥15.78B | 11.23 | 2.61% | 12.54% | 52.02% | ||
79 Outperform | ¥13.66B | 10.54 | 3.83% | 2.13% | 7.67% | ||
78 Outperform | ¥15.91B | 11.16 | 3.17% | 8.46% | 3.01% | ||
78 Outperform | ¥15.72B | 7.85 | 3.94% | 7.93% | 20.67% | ||
68 Neutral | ¥13.74B | 20.27 | 3.65% | -2.98% | -31.07% | ||
62 Neutral | $11.81B | 10.34 | -7.44% | 2.91% | 7.41% | -7.93% |